DAFNA Capital Management LLC - PREVAIL THERAPEUTICS INC ownership

PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 47 filers reported holding PREVAIL THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of PREVAIL THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$1,730,000
+126.4%
75,0000.0%0.52%
+107.7%
Q3 2020$764,000
-31.7%
75,0000.0%0.25%
-23.2%
Q2 2020$1,118,000
+22.3%
75,0000.0%0.32%
-15.2%
Q1 2020$914,000
-23.0%
75,0000.0%0.38%
-6.4%
Q4 2019$1,187,000
+28.9%
75,0000.0%0.41%
+17.6%
Q3 2019$921,000
-7.0%
75,0000.0%0.35%
-7.0%
Q2 2019$990,00075,0000.37%
Other shareholders
PREVAIL THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Orbimed Advisors 13,822,463$318,884,0002.79%
HARVEST MANAGEMENT LLC 70,000$1,615,0001.32%
HARVEST MANAGEMENT LLC 70,000$1,615,0001.32%
EQUITEC PROPRIETARY MARKETS, LLC 215,300$4,967,0001.30%
BARDIN HILL MANAGEMENT PARTNERS LP 206,867$4,773,0001.00%
Boxer Capital, LLC 1,123,105$25,910,0000.83%
TIG Advisors, LLC 709,282$16,363,0000.82%
Newtyn Management, LLC 153,617$3,544,0000.82%
ALPINE ASSOCIATES MANAGEMENT INC. 857,705$19,787,0000.81%
GABELLI & Co INVESTMENT ADVISERS, INC. 205,800$4,748,0000.74%
View complete list of PREVAIL THERAPEUTICS INC shareholders